Mealey's (May 2, 2023, 2:37 PM EDT) -- MIAMI — The lead plaintiff in a securities class action against a clinical-stage biopharmaceutical company, certain of its officers and managers and underwriters of the company’s initial public offering (IPO) asked a federal judge in Florida to preliminarily approve a nearly $1.4 million settlement, saying the deal is fair, reasonable and adequate and meets the statutory requirements for approval....